Speakers

Andrew Jack, Pharmaceuticals and Healthcare Correspondent, Financial Times

Professor the Lord Darzi, Head of Surgery, Imperial College London and former Health Minister, UK Government

Martin Donnelly, Acting Permanent Under-Secretary of State, Foreign and Commonwealth Office, UK Government

Vicky Chen, Partner, China Healthcare Partnership, Martin Currie China

Min Liang, Vice President and CSO, TTY Oncology (TOT), TTY Biopharm

Li Ling, Professor of Economics, China Center for Economic Research, Peking University

Zhang Wei, Assistant Professor of Management, China Europe International Business School (CEIBS)

Wang Xiaochuan, Chairman and CEO, Sundia MediTech

Carl Firth, CEO, ASLAN Pharmaceuticals

Ben Zhou, Vice President and Managing Director, Dell Services Public Sector, Greater China

Wilf Blackburn, CEO, Allianz China Life Insurance

James Li, Partner, Kleiner Perkins Caulfield & Byers

Emmanuel Puginier, Chairman, Greater China Region, Novartis

Ronald Ede, Chief Financial Officer, Mindray Medical International

Canwen Jiang, Vice President and Head of R&D Asia, Genzyme Corporation

Sarah Barber, Team Leader, Health Policy and Systems, World Health Organisation

Frank Grams, Executive Director, Roche Partnering

Roberta Lipson, CEO, Chindex International and Board Chair, United Family Hospitals and Clinics

Rick Mills, Group Director of Strategy and Corporate Development, Alliance Boots

George Baeder, Partner and Vice President, Monitor Group Asia

Lewis Ho, Partner, Simmons & Simmons

Rajesh Parekh, Director, Head of Healthcare Practice - Asia, McKinsey & Company